Despite intense effort, obesity is still rising throughout the world. Links between obesity and cardiovascular diseases are now well established. Most of the cardiovascular changes related to obesity can be followed by magnetic resonance imaging (MRI) or by magnetic resonance spectroscopy (MRS). In particular, we will see in this review that MRI/MRS is extremely well suited to depict (1) changes in cardiac mass and function, (2) changes in stroke volume, (3) accumulation of fat inside the mediastinum or even inside the cardiomyocytes, (4) cell viability and (5) molecular changes during early cardiovascular diseases.
Introduction
Despite intense public health effort to provide information and education, the prevalence of obesity is still rising throughout the world. The strong association between obesity and cardiovascular diseases is now well accepted and documented. 1, 2 It is common knowledge that hemodynamic (increased cardiac output and hypertension) and metabolic (dyslipidemia) derangements associated with obesity may predispose to coronary artery disease and heart failure. Nonetheless, a direct toxic effect of lipid on the myocardium is now recognized. Lipid accumulation inside the cardiomyocytes is believed to be cardiotoxic and responsible for left ventricular remodeling and dilated cardiomyopathy. 3 Obese patients typically have more than one Framingham risk factor, including hypertension, dyslipidemia and diabetes mellitus. All these risk factors predispose the obese person to myocardial infarction (MI), which may lead to ischemic cardiomyopathy. Other well-known landmarks of obesity are an increased heart rate and stroke volume, which are believed to be a compensatory mechanism for increased fat mass 4 at the expense of eccentric left ventricle (LV) remodeling. In morbid obesity, this increased workload of the heart can even lead to non-ischemic dilated cardiomyopathy. 5 In this review, we will discuss the impact that imaging can have on obese patients in terms of diagnoses related to cardiovascular diseases. The place of magnetic resonance imaging (MRI) in heart imaging and in the evaluation of the treatment of obesity will be discussed. We will consider (1) the role of MRI in assessing cardiac mass and function, (2) the role of MRI in assessing fat content of the mediastinum and of the heart (cardiac steatosis), (3) the implication of MRI in assessing MI, (4) the role of MRI in cell imaging and finally (5) the future role of molecular imaging in cardiology.
four-cavity view and a short-axis view. Cine imaging, tag imaging, and injection of contrast media, could be added depending on the clinical questions.
As the heart is constantly moving (heart contraction), all acquisitions need to be ECG gated. The heart is also moving during breathing, to compensate for the respiratory movements; the acquisition could be either respiratory gated or the images need to be acquired during breath hold. 9 Another option for the patient incapable of sufficient apnea is to use real-time MRI. Using extremely fast imaging techniques (that is, acquisition time of the order of a few ms), it is possible to acquire MR images of the heart without ECG and respiratory gating. This could also be a major advantage for patients suffering from severe arrhythmias. During the last few years, cardiac MRI has become the gold standard for the evaluation of ventricular mass, volumes and function, imaging of myocardial scar, assessment of myocardial viability and imaging of congenital heart disease. 10 Cardiac mass: evaluation of the LV mass and its implication in the clinic Cardiac hypertrophy (an increase in heart mass) is an important clinical parameter that is implicated in almost all forms of heart failure. 11 The heart of an athlete is one of the few exceptions, in which chronic exercise induces hypertrophic response, but with preserved or even enhanced cardiac function. 12, 13 In the adult, the heart responds to a functional overload (either by pressure or by volume) by a hypertrophy to counterbalance wall stress. (LV) and the left atrium (LA) can be seen, a four-cavity view, where the four cardiac chambers can be seen and a short axis view, where the right and left ventricles can be seen. (b) Cine-type MRI allows contraction of the ventricles to be followed during the cardiac cycle. The diameter of the LV being larger during the diastole (D) and smaller during the systole (S). (c) Tag imaging allows assessment of regional contraction/function. By superimposing a black tag line on a cine type of images, cardiac deformation during contraction can be followed. In the presented case, there are no changes in the circumferential strain in the infarct area, whereas a good contraction is seen in the remote region. A color-coded map was also superimposed on the tag images to facilitate visual analysis. Blue, minimum contraction; Red, maximum contraction; RA, right atrium; RV, right ventricle.
Cardiovascular MRI is now considered the gold standard for left ventricular function and mass assessment.
14 An accurate evaluation of the mass of the LV implies good segmentation of the endocardial and epicardial contour. The best plane to evaluate the LV mass is the short-axis plane, because the partial volume is minimal in this direction.
Once the volume of the LV is known, a simple multiplication by muscle-specific weight gives the LV mass ( Figure 2 ). In the most recent MR scanners, this can be done automatically.
Ventricular function
Global function versus regional function Global LV function can be assessed through the ejection fraction. Accurate and reproducible measurement of the left ventricular ejection fraction is of primary importance in the diagnostic workup of a patient. An easy way to assess the global left ventricular ejection fraction is to trace the endocardial and epicardial borders at end diastole and end systole in different planes. This could be time-consuming, more particularly, if the entire heart volume is acquired. The modified Simpson's method allows the measurement of the left ventricular ejection fraction with high accuracy compared with the full three-dimensional reconstruction method 15 ( Figure 3a) . The modified Simpson's method consists of acquiring two short-axis views and one long-axis view, hence reducing acquisition (and analysis) time, when compared with full coverage of the LV. With regard to the regional function, two MR techniques can provide strain curves: DENSE 16, 17 and TAGGING. 18, 19 Myocardial tagging allows assessment of the regional function of the LV. In this method, black tag lines are imprinted over a cine-MRI, allowing analysis of cardiac rotation, strain, displacement and deformation of the different myocardial layers during the cardiac cycle (Figure 3b ). Assessing cardiac function at the regional level is of utmost importance in clinics, because a small contraction deficit will not always have a repercussion on the global function. Nevertheless, MRI and MRS to evaluate cardiovascular pathophysiology K Montet-Abou et al small contraction deficits have to be detected and should help to better stratify patients.
Fat deposits and fat imaging
Dixon techniques for fat imaging MRI is extremely well suited to perform specific fat imaging. Most of the MR signal comes from protons in water and in fat. It is known that water protons precess a little faster than fat protons. Hence, water and fat proton will be in-phase and out-phase regularly. The signal of both protons will be added when in phase, whereas their respective signal will be subtracted when out of phase 20 ( Figure 4 ). From this, it is possible to generate a water-containing image and a fatcontaining image (Figure 4 ). Since its first description in 1984, this way of imaging water and fat has been improved, and is still an important research area. 21, 22 Fat imaging is also almost part of clinical practice. 23 Mediastinal lipomatosis. Mediastinal lipomatosis is a benign condition that is characterized by an unencapsulated fat deposit in the mediastinum. This condition could be related to the exogenous use of steroids, Cushing's syndrome or obesity. 24 As MR has the propensity to image water and fat images, the mediastinal fat depot could easily be imaged ( Figure 5 ). The Dixon techniques are well suited to image fat, at least when the quantity of fat is sufficiently high. This technique is not sensitive enough to detect subtle fat depots in organs. In that case, magnetic resonance spectroscopy (MRS) should be preferred.
Magnetic resonance spectroscopy MRS is a non-invasive technique allowing one to assess/ measure the presence of different metabolites in the human body and hence represents a first form of molecular imaging. 25 Depending on the nuclei, which are under investigation, different informations can be retrieved. For example, looking at 31 P will allow investigation of highenergy metabolism (through adenosine triphosphateadenosine diphosphate metabolism), whereas looking at 23 Na will allow assessment of myocardial viability.
26,27
Figure 4 It was shown that the measured Na concentration in vivo by MRS was consistent with previous measures made on a biopsy or autopsy specimen. 27 In the context of obesity, the quantitation of triglyceride throughout the body should be of clinical value. It has been shown that based on 1 H MRS, triglyceride (more precisely CH2/CH3 groups) content can be quantified. 28, 29 More importantly, not only could the quantity of the fat depot be non-invasively assessed, but also the fat quality. MRS is based on spectra ( Figure 6 ), which are localized on classic MR images. The area under the curve corresponds to the quantitative measure of the metabolite of interest. Figure 5 Water and fat images. After signal processing, water and fat images could be generated. On the water image, the fat appears hypointense (dark), whereas on the fat images, the fat appears hyperintense (bright). Also note the presence of fat inside the medastinum. Cardiac steatosis. Cardiac steatosis (accumulation of fat droplets inside cardiomyocytes) was first recognized as a possible cause of cardiomyopathy in the beginning of the twentieth century, 30 but was called into question in the middle of the century, leading to disinterest for the next several decades. Nowadays, the implication of cardiac steatosis in cardiomyopathy through direct lipotoxic injuries is being reconsidered. 1, 31 One good example of such a pathology is diabetic cardiomyopathy. Recent reports suggest that the accumulation of fatty acid intermediates may cause mitochondrial dysfunction and production of oxygen reactive species, leading to myocardial dysfunction. 31, 32 Importantly, it has been shown that the reduction of cardiac steatosis has a beneficial effect on myocardial function. 31 MRS and MRI are an almost perfect couple to study cardiac steatosis. MRI allows localization for MRS, and MRS itself will give some insight on the quantity and quality of intra-myocardial lipids ( Figure 6 ). Nevertheless, the quantification of cardiac steatosis remains challenging, essentially because the acquisition of the spectra needs a double trigger (ECG and respiratory). It has also been shown that myocardial triglycerides decrease after energy restriction in obese type 2 diabetes patients 33, 34 and that this decrease in myocardial triglycerides is associated with better cardiac function.
MI: viability sequences
During MI, cellular death propagates from the endocardium to the epicardium, with a scar (fibrosis) replacing a variable amount of myocardium. This will result in impaired contraction. Nevertheless, a contraction deficit is not always related to fibrosis, but could also be associated with myocardial stunning or myocardial hibernation. 35 Myocardial stunning Myocardial stunning is defined as a contraction deficit persisting for a few weeks even after successful revascularization. This contraction deficit will spontaneously resolve. [36] [37] [38] [39] Two of the hypotheses to explain this state are the deleterious effects of reperfusion due to oxygen species and impaired calcium homeostasis.
Myocardial hibernation
Myocardial hibernation has been 'borrowed' from a zoology term and applied to a particular heart condition, in which there is an adaptative reduction of cardiac contraction following a reduction of myocardial blood flow. It implies that this condition is reversible to a normal state after flow restoration. Hence, myocardial hibernation is a protective mechanism to preserve myocardial integrity and viability. 40, 41 From a clinical point of view, it is important to detect patients for whom a revascularization procedure will be efficient. It is known that a patient having a decreased LV function, without much myocardial viability, will suffer from increased perioperative and long-term mortality rates when subject to revascularization. 42 Hence, it is important to discriminate between viable and non-viable myocardium during the workup of the patient with ischemic cardiomyopathy, to select patients who will benefit from a revascularization procedure. Myocardial viability can be assessed using various MRI techniques, such as delayed contrast-enhanced MRI and perfusion imaging.
Delayed contrast-enhancement imaging Nowadays, delayed contrast enhancement is considered the most accurate method to detect a myocardial scar and evaluate its transmural extension. The mechanism of enhancement is believed to be a combination of delayed wash-in/wash-out and a different volume of distribution of the gadolinium compound in the region of the myocardium suffering from ischemia.
14 Acute and chronic MI appear hyperintense (bright) after a gadolinium injection on delayed T1-weighted sequences. Delayed images have to be acquired between 10 and 30 min post-injection of the contrast media. 43 A too early acquisition will overestimate the size of the myocardial infarct, 44 whereas a too late acquisition will result in poor contrast to noise ratio, due to an excessive wash out of the contrast media. It is important to remember that not only will the time post-injection influence the size of the myocardial infarct, but also the type of MR sequences used. The use of segmented inversion-recovery-prepared fast gradient echo sequences, with an inversion time between 175 and 250 ms, is now the type of recommended sequences for myocardial infarct imaging. The inversion time is chosen to null the signal of the normal myocardium and hence increase the contrast between the infarcted area and the normal part of the myocardium (Figure 7) . A scar or fibrosis following MI will appear hyperintense on late contrastenhanced images and will typically be subendothelial or transmural in a coronary territory. Owing to its high spatial resolution (in the order of 2 Â 2 mm), a contrast-enhanced MRI is superior to nuclear medicine in assessing a small subendocardial infarct. 45 Even though late enhancement was primarily developed for MI evaluation, it should be emphasized that late enhancement is not pathognomonic of MI, but is also seen during inflammatory or infectious diseases of the myocardium, cardiomyopathy, cardiac neoplasms, and congenital or genetic cardiac conditions, as well as after cardiac interventions. Nevertheless, in these cases the late enhancement does not follow a coronary territory and is often located in the midwall rather than in the subendothelial region or transmural.
The mechanism behind late enhancement depends on the pathology that is studied. The fibrous scar tissue of a myocardial infarct tends to retain the contrast media, whereas an increase in the distribution volume of the contrast media is seen during an acute myocardial infarct or during an inflammatory process. 46 Associated signs, such as wall thinning and/or the presence of an aneurysm, will help to diagnose a chronic MI, whereas late enhancement without atrophy should evoke an acute MI. More importantly, an image should always be placed in a clinical context, and in this case, differentiating an acute from a chronic myocardial infarct is more than obvious.
Perfusion imaging
Perfusion imaging is based on the repetitive acquisition of an image after the injection of contrast media. Changes in signal intensity over time are captured through fast imaging sequences, such as inversion recovery prepared fast gradient echo, interleaved gradient echo, echo-planar imaging and saturation recovery steady-state free precession sequences.
47-51
On such sequences, a myocardial infarct will appear hypointense (black) and will last for 20 s. When the hypointense signal lasts for a minute or more, a no-reflow phenomenon can be described (see below and Figure 8 ).
The no-reflow phenomenon
The no-reflow phenomenon is due to complete obstruction of the capillaries by micro-emboli and endothelial edema and may be encountered during an acute MI, despite successful revascularization. This phenomenon is associated with the absence of reperfusion in the territory without collateral flow, such as in the subendocardial region ( Figure 8) . A no-reflow phenomenon is associated with a poorer prognosis and could be a marker for a bad revascularization responder. 52 Moreover, the no-reflow phenomenon was found to be a significant predictor of late major adverse cardiac events. 53 Perfusion imaging could be determined at rest or during stress. In the majority of cases, stress imaging is obtained after pharmacological stimulation by dobutamine or adenosine. Such drugs act through vasodilatation and increase contractility of the myocardium. This results in an increased blood demand and an increased perfusion. When healthy coronary arteries are present, they are able to vasodilate and to deliver more blood to the myocardium. In the other hand, when moderate or severe stenoses are present on the coronary arteries, the flow is limited and stress imaging shows perfusion deficit and wall motion abnormalities. End-diastolic wall thickness 45.5 mm and evidence of wall thickening after dobutamine injection 41-2 mm have been considered viable criteria. 54 Therefore, stress imaging is able to detect coronary artery deficit in asymptomatic patients. Recent papers proposed to combine perfusion imaging with delayed contrast-enhanced MRI to increase the sensitivity/specificity of the method.
55,56
Quantification of myocardial fibrosis by T1 mapping Replacement of normal myocardium by fibrosis is an important clinical point implicated in numerous pathologies (at least after long evolution), such as cardiac graft rejection, 57 cardiomyopathy, 58 diabetes, hypertension 59, 60 and MI, and has major consequences on cardiac function. 61 On the basis of the T1-weighted parametric map, cardiac MRI is also able to detect myocardial fibrosis. [62] [63] [64] [65] Each tissue has a normal range of T1 relaxation times, 66 allowing definition of cutoff values to differentiate normal from abnormal relaxation times, and hence normal from pathological states. The method is sensitive enough not only to differentiate normal from infarcted areas, but also to differentiate acute from chronic MI. 64 Moreover, as T1 relaxation times are automatically calculated, differentiation between normal and abnormal tissue is made in an observer-independent manner ( Figure 9 ).
Cellular imaging
The use of nonspecific, extracellular contrast media (such as gadolinium chelates) is of great help in delineating pathology by MRI, but as previously discussed, the contrast between the pathological and normal part of the organ is only based on differences in wash-in/wash-out and distribution volume of the contrast media. To go one step forward in the direction of specific imaging, it would be interesting to have access to contrast media developed for specific cellular imaging. Such MR contrast media exist and comprise manganese chelates and iron oxide nanoparticles.
The use of manganese as an MR contrast media
Manganese was the first contrast media described for MRI by one of the pioneers in this field as early as in 1978. 67 This group discovered that the administration of manganese salt increased the signal of the liver, kidney and heart 68 on T1-weighted sequences. At that time, cardiotoxicity of manganese salt (by blocking normal calcium fluxes into the heart) prevented its use in clinics. Different strategies were then used to reduce the cardiotoxicity of manganese. The first one was to decrease the dose of Mn 2 þ , but despite an encouraging first result, these low doses of Mn 2 þ were still responsible of hypotension.
The second one was to use a chelate to remove free Mn 2 þ from the blood, and the third one was to co-inject Ca 2 þ to compete and reduce Mn 2 þ binding on the Ca 2 þ channels.
Chelation of Mn 2 þ by dipyridoxal diphosphate has led to the approval by the Food and Drug Administration of Mndipyridoxal diphosphate as a liver-specific contrast media. Despite its approval for liver imaging, Mn-dipyridoxal MRI and MRS to evaluate cardiovascular pathophysiology K Montet-Abou et al diphosphate could also be used to image calcium-dependent phenomenon.
Use of manganese as a calcium analogue. It was already proposed in 1980s by Hunter et al. 69 that Mn 2 þ uptake in the heart could be used to measure Ca 2 þ uptake, because Mn 2 þ enters the cardiomyocytes through Ca 2 þ channels 70 and stays in the cells for a long time. 69 It has been demonstrated in healthy volunteers that the uptake of Mn 2 þ is complete after 1 h and stays constant for B2 h. 71 Similarly, it has been shown that drugs known to influence Ca 2 þ uptake also influence Mn 2 þ uptake. Mn 2 þ uptake is increased by elevated heart rates because of adrenergic stimulation, whereas uptake is decreased in cases of increased Ca 2 þ concentration because of the presence of calcium blockers, such as verapamil and dihydropiridine (which is fairly specific for an L-type channel). 69, [72] [73] [74] The discovery that cardiotoxicity was mainly due to extracellular Mn 2 þ instead of intracellular Mn 2 þ and that the slow infusion of a low, non-toxic concentration of Mn 2 þ leads to high tissue accumulation prompts reuse of Mn-based contrast media for cardiac imaging. 75 Mn-enhanced cardiac MRI was then re-evaluated, particularly in the context of Mn 2 þ being a surrogate of Ca 2 þ uptake by cardiomyocytes. Recent studies obtained promising results in differentiating viable from non-viable segments in showing different enhancement. 73, 76 Hence, viable cells will take up Mn 2 þ , whereas dead cells will not ( Figure 10 ).
This differential uptake between the viable and non-viable cell could also be increased pharmacologically. 77 The use of iron oxide nanoparticles as an MR contrast media Superparamagnetic iron oxide (SPIO) nanoparticles were the first to be approved by the Food and Drug Administration for liver imaging in the 1980s. They induce a clear signal loss on T2-and T2*-weighted sequences, that is, the region containing iron turns black. In the context of liver imaging, SPIO nanoparticles have been demonstrated to increase lesion detection and characterization. SPIO also has a strong T1 effect, and has been used in the characterization of liver hemangiomas. 79, 80 SPIO-based cellular imaging has become an established technique to label and detect cells of interest. Two general ways could be followed to perform cellular imaging using SPIO. The first depends on the fact that SPIO is cleared from the blood by the reticulo-endothelial system, and hence could be used to image the macrophage activity during an inflammatory process. The second one is to load the cells ex vivo with SPIO (and transfection agents) and to reinject them into living beings and to track them by MRI. Even though ex vivo cell loading is widely used, this process is not straightforward and attention needs to be paid to the experimental conditions to decrease nonspecific adsorption MRI and MRS to evaluate cardiovascular pathophysiology K Montet-Abou et al on the cell surface and the precipitation of the SPIO during the process. 81, 82 Inflammation imaging. The classical way to image an inflammatory process is to inject SPIO and wait for their uptake by macrophages. This is an interesting approach, as it is known that inflammation is present in different conditions in the myocardium, such as during healing of an MI or during graft rejection. 83 This approach could also be used to image atherosclerotic plaques, as macrophage infiltration of the plaques occurs and seems to be correlated with unstable plaques. 84 Consistently good correlations between in vivo visualization of macrophages and histological staining have been found. [85] [86] [87] We have described a new way of performing inflammation imaging. We proposed to load the reticulo-endothelial system before induction of the inflammatory process, wait for the complete disappearance of the SPIO from the blood and then induce an inflammatory lesion. Hence, we were able to load in vivo the resting monocytes and show that they are mobilized to an inflammatory lesion (in this case, an acute myocardial infarct) ( Figure 11 , reprinted with permission from Montet-Abou et al.
88
). New generations of SPIO are now being developed. Their major advantages are (1) they are not cleared efficiently by the reticulo-endothelial system, allowing them to circulate for a longer time and (2) their surface can be modified to directly target specific receptors present on the surface of cells. This will lead to real molecular imaging, which will be discussed in the next section.
Molecular imaging
'Classical' imaging is used everyday in clinical cardiology to guide diagnosis and therapy, but only gives access to anatomical and/or structural information. On the other hand, molecular imaging will give access to the activity of a protein, the fate of a biomolecule and even to molecular pathways. Collectively, molecular imaging should help to better understand biological pathways in their native environment.
Molecular imaging agents have been designed for MR, [89] [90] [91] nuclear, 92, 93 optical, 94, 95 computed tomography 96 and ultrasound imaging. 97, 98 The agents are classically designed as activatable or targeted agents.
99
Activatable or 'smart' probes Activatable agents (also known as 'smart' agents, sensors, beacons) consist of chemically engineered substrates that undergo a physicochemical change after interacting with their intended target. This results in the activation of the contrast media. Hence, the non-modified agents are barely visible, whereas the modified agents become visible by imaging. Activatable MRI agents are generally based on one of two chemical principles: (1) enzymatic conversion of the agents 100 or (2) assembly-disassembly of the agents. 101, 102 In the first approach, the primary agent is almost magnetically silent because water cannot interact with the gadolinium. After enzymatic interaction (b-galactosidase in this case), one part on the agent is cleaved, allowing direct interaction between the water molecules and the paramagnetic ion, and hence appearance of the MR signal. In the second approach, enzyme-mediated polymerization of agents is used. The resulting polymers have a higher MR relaxivity and hence an increased MR signal.
Myeloperoxidase-activatable probes. It is well known that (1) monocytes/macrophages are recruited to the location of the myocardial infarct and (2) monocytes/macrophages produce a substantial amount of myeloperoxidase. Hence, an activatable agent capable of imaging myeloperoxidase has proved useful to image the inflammatory response during acute MI 103 ( Figure 12 , reprinted with permission from Nahrendorf et al.
103
). Moreover, as the myeloperoxidase level has been correlated with clinical outcome, 104 this new imaging technique should allow to better stratify the patient and, hence, detect the patient with a high risk of progression toward adverse remodeling after MI.
MR-targeted probes
Targeted MRI agents have largely been based on iron oxide nanoparticles and gadolinium chelates. Products based on gadolinium chelates suffer from lower intrinsic relaxivity (and hence detectability by MRI) and often necessitate larger-sized agents to achieve sufficient magnetic payload. Nonetheless, these agents have been proved to specifically image angiogenesis, 105, 106 progenitor cells 107 and thrombosis 108 in vivo.
The first strategy for targeted imaging is to add targeting moieties on the surface of iron oxide nanoparticles directed against known targets on the cell surface, such as a(v)b3 integrin, 106 ,109 E-selectin 95, 96, 110, 111 or vascular cell addition molecule. 112 In addition to being specific, such contrast media also benefit from biological amplification through cellular trapping. Cellular internalization is an important step to increase the signal-to-noise ratio of such contrast media. The presence of multiple targeting moieties on the surface of nanoparticles (that is, multivalency) has been proved to enhance internalization. 109 Such a strategy has been applied to apoptosis imaging in the heart following MI 113 ( Figure 13 , reprinted with permission from Sosnovik et al.
113
), and for the detection of apoptosis during chronic heart failure. 114 
Conclusion
MRI and MRS provide a non-invasive approach that is extremely well suited to evaluate cardiovascular pathophysiology. ).
MRI and MRS to evaluate cardiovascular pathophysiology K Montet-Abou et al These techniques allow evaluation of cardiac function at several levels. First, the whole organ could be assessed by cine-MRI; second, the regional level through tag, perfusion and viability imaging; third, the metabolic level could be assessed with MRS; and fourth, the processes at the cellular and even molecular level with molecular imaging. Even though molecular contrast media are not currently on the market, we strongly believe that in the next decade, currently promising MR molecular agents will be introduced in the clinics to guide diagnosis and therapy. They will allow early detection of cardiovascular diseases, better risk assessments and hopefully a better clinical outcome.
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